Celiac disease is a serious autoimmune disease that occurs in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. It is estimated to affect 1 in 100 people worldwide, but only about 30% are properly diagnosed.
Celiac Research Studies
Investigator
Takeda ILLUMINATE
Enrolling: Yes
Principle Investigator: Monika Fischer, MD
Duration: 32 weeks
Patient Population: Adult celiac patients with at lest 1 symptom, biopsy confirmed or blood test proving disease.
Study Intervention: Oral TAK-062
Interested in this study? Please contact our IBD research team: iuibd@iu.edu